Reduced apoptosis in term placentas from gestational diabetic pregnancies

Journal of Developmental Origins of Health and Disease

Volumn 4, Issue 3, 2013, Pages 256-265

  Belkacemi, Louiza ^a   Kjos, S ^a   Nelson, D M ^b   Desai, M ^a   Ross, M G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; gestational diabetes; macrosomia; placenta

Indexed keywords

EID: 84882375947     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174413000068     Document Type: Article

References (53)

1. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999; 180, 903-916.
2. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352, 2477-2486.
3. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999; 341, 1749-1756.
4. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet. 2009; 373, 1789-1797.
5. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006; 49, 270-283.
6. Higgins M, Mc Auliffe F. A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev. 2010; 6, 116-125.
7. Ashfaq M, Janjua MZ, Channa MA. Effect of gestational diabetes and maternal hypertension on gross morphology of placenta. J Ayub Med Coll Abbottabad. 2005; 17, 44-47.
8. Schafer-Graf UM, Dupak J, Vogel M, et al. Hyperinsulinism, neonatal obesity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. J Perinat Med. 1998; 26, 27-36.
9. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980; 29, 1023-1035.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. Suppl 1, S67-S74.
11. Belkacemi L, Chen CH, Ross MG, Desai M. Increased placental apoptosis in maternal food restricted gestations: role of the Fas pathway. Placenta. 2009; 30, 739-751.
12. Konstantinidou A, Patsouris E, Kavantzas N, Pavlopoulos PM, Bouropoulou V, Davaris P. Computerized determination of proliferating cell nuclear antigen expression in meningiomas. A comparison with non-automated method. Gen Diagn Pathol. 1997; 142, 311-316.
13. Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM. Caspase-mediated apoptosis of trophoblasts in term human placental villi is restricted to cytotrophoblasts and absent from the multinucleated syncytiotrophoblast. Reproduction. 2012; 143, 107-121.
14. Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM. Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR. Placenta. 2012; 33, 352-359.
15. Ivarsson K, Myllymaki L, Jansner K, Bruun A, Stenram U, Tranberg KG. Heat shock protein 70 (HSP70) after laser thermotherapy of an adenocarcinoma transplanted into rat liver. Anticancer Res. 2003; 23, 3703-3712.
16. Belkacemi L, Jelks A, Chen CH, Ross MG, Desai M. Altered placental development in undernourished rats: role of maternal glucocorticoids. Reprod Biol Endocrinol. 2011; 9, 105.
17. Liang M, Ekblad E, Gustafsson JA, Nilsson BO. Stimulation of vascular protein synthesis by activation of oestrogen receptor beta. J Endocrinol. 2001; 171, 417-423.
18. Taricco E, Radaelli T, Rossi G, et al. Effects of gestational diabetes on fetal oxygen and glucose levels in vivo. Bjog. 2009; 116, 1729-1735.
19. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol. 1997; 177, 1395-1401.
20. Axt R, Meyberg R, Mink D, Wasemann C, Reitnauer K, Schmidt W. Immunohistochemical detection of apoptosis in the human term and post-term placenta. Clin Exp Obstet Gynecol. 1999; 26, 56-59.
21. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest. 1994; 94, 2105-2116.
22. Jansson T, Cowley EA, Illsley NP. Cellular localization of glucose transporter messenger RNA in human placenta. Reprod Fertil Dev. 1995; 7, 1425-1430.
23. Ericsson A, Hamark B, Powell TL, Jansson T. Glucose transporter isoform 4 is expressed in the syncytiotrophoblast of first trimester human placenta. Hum Reprod. 2005; 20, 521-530.
24. Taricco E, Radaelli T, Nobile de Santis MS, Cetin I. Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta. 2003; 24, 343-347.
25. Kucuk M, Doymaz F. Placental weight and placental weight-tobirth weight ratio are increased in diet- and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test. J Diabetes Complications. 2009; 23, 25-31.
26. Mayhew TM, Sorensen FB, Klebe JG, Jackson MR. The effects of mode of delivery and sex of newborn on placental morphology in control and diabetic pregnancies. J Anat. 1993; 183, 545-552.
27. Ericsson A, Saljo K, Sjostrand E, et al. Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport. J Physiol. 2007; 581, 1323-1332.
28. Mayhew TM, Sorensen FB, Klebe JG, Jackson MR. Growth and maturation of villi in placentae from well-controlled diabetic women. Placenta. 1994; 15, 57-65.
29. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995; 21, 1465-1468.
30. Mundle SD, Raza A. The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest. 1995; 72, 611-613.
31. Cervos-Navarro J, Schubert TE. Pitfalls in the evaluation of apoptosis using TUNEL. Brain Pathol. 1996; 6, 347-348.
32. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35, 495-516.
33. de Boer RA, van Veldhuisen DJ, van der Wijk J, et al. Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure. J Card Fail. 2000; 6, 330-337.
34. Sgarbosa F, Barbisan LF, Brasil MA, et al. Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract. 2006; 73, 143-149.
35. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995; 376, 37-43.
36. Stennicke HR, Salvesen GS. Properties of the caspases. Biochim Biophys Acta. 1998; 1387, 17-31.
37. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995; 81, 801-809.
38. Le Rhun Y, Kirkland JB, Shah GM. Cellular responses to DNA damage in the absence of Poly(ADP-ribose) polymerase. Biochem Biophys Res Commun. 1998; 245, 1-10.
39. Wheeler PD, Yudilevich DL. Effect of insulin, prostaglandin E1 and uptake inhibitors on glucose transport in the perfused guinea-pig placenta. J Dev Physiol. 1989; 11, 159-169.
40. Desoye G, Gauster M, Wadsack C. Placental transport in pregnancy pathologies. Am J Clin Nutr. 2011; 94(Suppl 6), 1896S-1902S.
41. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol. 2001; 18, 247-256.
42. Korgun ET, Demir R, Hammer A, et al. Glucose transporter expression in rat embryo and uterus during decidualization, implantation, and early postimplantation. Biol Reprod. 2001; 65, 1364-1370.
43. Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. J Clin Endocrinol Metab. 1999; 84, 695-701.
44. Hauguel-de Mouzon S, Leturque A, Alsat E, Loizeau M, Evain-Brion D, Girard J. Developmental expression of Glut1 glucose transporter and c-fos genes in human placental cells. Placenta. 1994; 15, 35-46.
45. Grissa O, Yessoufou A, Mrisak I, et al. Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth. 2010; 10, 7.
46. Burleigh DW, Stewart K, Grindle KM, Kay HH, Golos TG. Influence of maternal diabetes on placental fibroblast growth factor-2 expression, proliferation, and apoptosis. J Soc Gynecol Investig. 2004; 11, 36-41.
47. Hill DJ, Tevaarwerk GJ, Caddell C, Arany E, Kilkenny D, Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: relationship to fetal and placental size. J Clin Endocrinol Metab. 1995; 80, 2626-2632.
48. Boileau P, Mrejen C, Girard J, Hauguel-de Mouzon S. Overexpression of GLUT3 placental glucose transporter in diabetic rats. J Clin Invest. 1995; 96, 309-317.
49. Hauguel-de Mouzon S, Challier JC, Kacemi A, Cauzac M, Malek A, Girard J. The GLUT3 glucose transporter isoform is differentially expressed within human placental cell types. J Clin Endocrinol Metab. 1997; 82, 2689-2694.
50. Thomas CR, Eriksson GL, Eriksson UJ. Effects of maternal diabetes on placental transfer of glucose in rats. Diabetes. 1990; 39, 276-282.
51. Baptiste-Roberts K, Nicholson WK, Wang NY, Brancati FL. Gestational diabetes and subsequent growth patterns of offspring: the National Collaborative Perinatal Project. Matern Child Health J. 2012; 16, 125-132.
52. Makhseed M, Musini VM, Ahmed MA, Al-Harmi J. Placental pathology in relation to the White's classification of diabetes mellitus. Arch Gynecol Obstet. 2002; 266, 136-140.
53. Fowden AL, Forhead AJ, Coan PM, Burton GJ. The placenta and intrauterine programming. J Neuroendocrinol. 2008; 20, 439-450.